Closure of Trading Window
Filed with BSE · · 1 page · English
Summary by 6ix AI
Chandra Bhagat Pharma Ltd. has announced the closure of its trading window for all directors, officers, and key managerial personnel due to insider trading regulations. This decision is in accordance with the company's internal procedures and the Securities and Exchange Board of India regulations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Chandra Bhagat Pharma Ltd. on 6ix
Earlier from Chandra Bhagat Pharma
- Chandra Bhagat Pharma Ltd. Press Release Sep 01 2026
- Chandra Bhagat Pharma Ltd. Press Release Aug 06 2026
- Chandra Bhagat Pharma Ltd. Press Release Aug 05 2026
- Chandra Bhagat Pharma Ltd. Press Release May 25 2026
- Chandra Bhagat Pharma Ltd. Press Release Apr 21 2026
Later from Chandra Bhagat Pharma
- Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 For Receipt Of BSE IP Approval
- Certificate For Non-Applicability Of Corporate Governance For The Quarter Ended 30Th September, 2026.
- Announcement under Regulation 30 (LODR)-Allotment
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Follow Chandra Bhagat Pharma into a list and get an email when it puts out news.
Follow Chandra Bhagat Pharma